Deriglidole

CAS: 122830-14-2

Ref. 3D-XEA83014

Produktinformation

• Name: Deriglidole
• Synonyme: Deriglidole [INN], (+)-1,2,4,5-Tetrahydro-2-(2-imidazolin-2-yl)-2-propylpyrrolo(3,2,1-hi)indole, Unii-68Ep8R4Pmv, 2-(4,5-dihydro-1H-imidazol-2-yl)-2-propyl-1,2,4,5-tetrahydropyrrolo[3,2,1-hi]indole

Beschreibung

Deriglidole is a drug that acts on atp-sensitive potassium channels and is used for the treatment of bowel disease in diabetic patients. It has been shown to have an inhibitory effect on fatty acid release from adipose tissue, which may be related to its ability to reduce insulin resistance and metabolic disorders. Deriglidole also inhibits the release of norepinephrine in the central nervous system, which may be due to its effect on ATP-sensitive potassium channels. Deriglidole has been shown to have an analog with clonidine, a drug used for the treatment of cancer. Clonidine has shown efficacy in treating various types of cancer.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 255.36 g/mol
• Formel: C₁₆H₂₁N₃
• Reinheit: Min. 95%